NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles


  • Research at NDA
  • Research Papers
  • Research Articles
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Capital Markets Hotline
  • Companies Act Series
  • Climate Change Related Legal Issues
  • Competition Law Hotline
  • Corpsec Hotline
  • Court Corner
  • Cross Examination
  • Deal Destination
  • Debt Funding in India Series
  • Dispute Resolution Hotline
  • Education Sector Hotline
  • FEMA Hotline
  • Financial Service Update
  • Food & Beverages Hotline
  • Funds Hotline
  • Gaming Law Wrap
  • GIFT City Express
  • Green Hotline
  • HR Law Hotline
  • iCe Hotline
  • Insolvency and Bankruptcy Hotline
  • International Trade Hotlines
  • Investment Funds: Monthly Digest
  • IP Hotline
  • IP Lab
  • Legal Update
  • Lit Corner
  • M&A Hotline
  • M&A Interactive
  • Media Hotline
  • New Publication
  • Other Hotline
  • Pharma & Healthcare Update
  • Private Client Wrap
  • Private Debt Hotline
  • Private Equity Corner
  • Real Estate Update
  • Realty Check
  • Regulatory Digest
  • Regulatory Hotline
  • SEZ Hotline
  • Social Sector Hotline
  • Tax Hotline
  • Technology & Tax Series
  • Technology Law Analysis
  • Telecom Hotline
  • The Startups Series
  • White Collar and Investigations Practice
  • Yes, Governance Matters.
  • Japan Desk ジャパンデスク

Pharma & Healthcare Update

1234
TITLE 
DATE 
First Exclusive Marketing Rights granted to Indian Pharmaceutical Company
09-25-2003
FDI in Pharma stays at 100% but with certain restrictions
11-16-2011
Draft Compensation Formula for Clinical Trial Related Injury Proposed
06-12-2014
Doctors under watch for Professional Misconduct - National Medical Commission in action
06-29-2022
DISHA: The first step towards securing patient health data in India
07-26-2018
Destination India: Fastest growing Asian hub for clinical trials
10-14-2005
Dawn of a New Era: All Medical Devices in India to be Regulated from April 2020
02-17-2020
COVID-19 and Vaccines Regulatory Update: The Story Thus Far
12-27-2021
Compensation for injuries in clinical trials getting regulated Ethics Committee decision final
12-23-2011
Commercialisation of healthcare in India: overview
04-01-2021
Clinical Trials On Trial
01-30-2013
Clinical Trials - Added Stringent Measures On Their Way!
04-22-2009
Clinical Trial Related Information Exempted from Disclosure
06-16-2011
Bar Coding Requirement For Secondary Level Packaging Of Exported Medicines Enforced On January 1, 2013
01-23-2013
Additional Compliances for Clinical Trials Prescribed
12-03-2013

Mission and Vision


Distinctly Different

What's New


AIFs due for closure struggle to sell holdings in startup firms
Quotes: August 11,2022
SEBI Amends Intermediaries Regulations: Another Step Towards Effective Regulation
Regulatory Hotline : August 10,2022

Events


Webinars

Transformative Innovations for the Digital Economy in India
July 27,2022 - September 14,2022

Seminar

Navigating Disputes in India
February 26,2020 - February 26,2020

This event is over. For event material please click here


Round Table

Investing In Net Zero
July 22,2022 - July 22,2022

This event is over. For event material please click here

News Roundup


News Articles

Supreme Court: Personal Guarantors can be made liable under Insolvency Code prior to any action against Principal Borrower
July 06,2022

Quotes

AIFs due for closure struggle to sell holdings in startup firms
August 11,2022

Newsletters


Regulatory Hotline

SEBI Amends Intermediaries Regulations: Another Step Towards Effective Regulation
August 10,2022

M&A Hotline

SEBI’s Conservative Guidance to Deepak Nitrite Limited
August 05,2022

Climate Change Related Legal Issues

Climate Change Related Legal Issues (Part 2) – Contracts & Disputes Between Private Parties
August 04,2022

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.